TXMD

0.94

6.00% -0.06

Handel nachbörslich: .94

Therapeuticsmd Inc (TXMD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.00

Offen:

$0.98

24-Stunden-Volumen:

24,906

Relative Volume:

0.05

Marktkapitalisierung:

$11.30M

Einnahmen:

$996.00K

Nettoeinkommen (Verlust:

$-6.09M

KGV:

-1.7736

EPS:

-0.53

Netto-Cashflow:

$-9.76M

1W Leistung:

-10.48%

1M Leistung:

+8.67%

6M Leistung:

-41.25%

1J Leistung:

-57.75%

1-Tages-Spanne:

$0.94

$1.03

1-Wochen-Bereich:

$0.92

$1.07

52-Wochen-Spanne:

$0.70

$2.44

Therapeuticsmd Inc Stock (TXMD) Company Profile

Firmenname

Therapeuticsmd Inc

Sektor

Healthcare (1161)

Branche

Drug Manufacturers - Specialty & Generic (1)

Telefon

561-961-1900

Adresse

951 YAMATO ROAD, SUITE 220, BOCA RATON, FL

Mitarbeiter

Twitter

@TherapeuticsMD

Nächster Verdiensttermin

2025-03-31

Neueste SEC-Einreichungen

TXMD's Discussions on Twitter

Vergleichen Sie TXMD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TXMD Therapeuticsmd Inc	0.94	11.30M	996.00K	-6.09M	-9.76M	-0.53
ZTS Zoetis Inc	159.61	73.88B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.19	48.17B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.45	47.59B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	14.85	17.28B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	307.37	13.78B	2.76B	1.11B	898.10M	22.77

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-08-07	Herabstufung	Jefferies	Hold → Underperform
2020-05-19	Herabstufung	JP Morgan	Overweight → Neutral
2019-12-02	Eingeleitet	Guggenheim	Buy
2019-10-17	Eingeleitet	H.C. Wainwright	Buy
2019-04-30	Fortgesetzt	Noble Capital Markets	Outperform
2018-06-15	Eingeleitet	JP Morgan	Overweight
2017-09-08	Eingeleitet	Morgan Stanley	Equal-Weight
2017-07-11	Hochstufung	Oppenheimer	Perform → Outperform
2017-05-09	Herabstufung	Oppenheimer	Outperform → Perform
2016-11-22	Fortgesetzt	Jefferies	Buy
2016-11-22	Eingeleitet	Oppenheimer	Outperform
2016-11-07	Fortgesetzt	Guggenheim	Buy
2016-04-04	Eingeleitet	Goldman	Buy
2015-12-08	Bestätigt	Jefferies	Buy
2015-12-08	Bestätigt	Stifel	Buy
2015-09-21	Bestätigt	Jefferies	Buy
2015-06-09	Eingeleitet	Guggenheim	Buy
2014-07-08	Eingeleitet	FBR Capital	Outperform
2014-04-17	Bestätigt	Noble Financial	Buy
2014-01-28	Bestätigt	Noble Financial	Buy

Alle ansehen

Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten

Apr 02, 2025

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 02, 2025

TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com - Defense World

Apr 02, 2025

Mar 31, 2025

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 31, 2025

Mar 29, 2025

TherapeuticsMD Full Year 2024 Earnings: US$0.20 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance

Mar 29, 2025

TherapeuticsMD Reports Improved Financial Performance - TipRanks

Mar 29, 2025

Mar 28, 2025

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Mar 28, 2025

Mar 27, 2025

DEADLINE MONDAY: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 -- TXMD - ACCESS Newswire

Mar 27, 2025